Cargando…
Gallbladder Cancer With Jaundice: Surgery Versus No Surgery
Background Patients with gallbladder carcinoma (GBC) and jaundice have a poor prognosis. The surgical management of these patients is controversial. There is a dearth of studies comparing curative surgical resection (CR) versus non-curative resection/palliation (NCR) in patients with GBC and jaundic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679131/ https://www.ncbi.nlm.nih.gov/pubmed/36420237 http://dx.doi.org/10.7759/cureus.30594 |
_version_ | 1784834126389444608 |
---|---|
author | K, Sugumaran Jajal, Vasistha M Nekarakanti, Phani K Choudhary, Devendra Nag, Hirdaya H |
author_facet | K, Sugumaran Jajal, Vasistha M Nekarakanti, Phani K Choudhary, Devendra Nag, Hirdaya H |
author_sort | K, Sugumaran |
collection | PubMed |
description | Background Patients with gallbladder carcinoma (GBC) and jaundice have a poor prognosis. The surgical management of these patients is controversial. There is a dearth of studies comparing curative surgical resection (CR) versus non-curative resection/palliation (NCR) in patients with GBC and jaundice. Hence, this study aimed to compare the outcomes between CR and NCR in these patients. Methodology This was a retrospective study on patients with GBC and jaundice managed by a single surgical unit at a tertiary care center in northern India from May 2009 to March 2021. These patients were grouped into CR or NCR. The clinical demographical profile and overall survival (OS) were compared between the groups. Results A total of 82 patients with GBC and jaundice were managed during the study period. The final study cohort included 59 patients (CR, n = 34; NCR, n = 25) after excluding patients with metastatic disease (n = 23). Common bile duct infiltration was seen in 61.7% and 84% of CR and NCR patients, respectively (p = 0.062). The overall tumor-node-metastasis staging between the two groups was similar (p = 0.296). The median OS of CR was significantly better in CR than NCR (20 months vs. six months; p = 0.001). The median OS was better in CR than NCR patients who received systemic chemotherapy (22 vs. 12 months; p = 0.001) or did not receive chemotherapy (14 months vs. three months; p = 0.001). Conclusions Patients with GBC and jaundice have better significant survival after CR than NCR alone. |
format | Online Article Text |
id | pubmed-9679131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-96791312022-11-22 Gallbladder Cancer With Jaundice: Surgery Versus No Surgery K, Sugumaran Jajal, Vasistha M Nekarakanti, Phani K Choudhary, Devendra Nag, Hirdaya H Cureus Gastroenterology Background Patients with gallbladder carcinoma (GBC) and jaundice have a poor prognosis. The surgical management of these patients is controversial. There is a dearth of studies comparing curative surgical resection (CR) versus non-curative resection/palliation (NCR) in patients with GBC and jaundice. Hence, this study aimed to compare the outcomes between CR and NCR in these patients. Methodology This was a retrospective study on patients with GBC and jaundice managed by a single surgical unit at a tertiary care center in northern India from May 2009 to March 2021. These patients were grouped into CR or NCR. The clinical demographical profile and overall survival (OS) were compared between the groups. Results A total of 82 patients with GBC and jaundice were managed during the study period. The final study cohort included 59 patients (CR, n = 34; NCR, n = 25) after excluding patients with metastatic disease (n = 23). Common bile duct infiltration was seen in 61.7% and 84% of CR and NCR patients, respectively (p = 0.062). The overall tumor-node-metastasis staging between the two groups was similar (p = 0.296). The median OS of CR was significantly better in CR than NCR (20 months vs. six months; p = 0.001). The median OS was better in CR than NCR patients who received systemic chemotherapy (22 vs. 12 months; p = 0.001) or did not receive chemotherapy (14 months vs. three months; p = 0.001). Conclusions Patients with GBC and jaundice have better significant survival after CR than NCR alone. Cureus 2022-10-22 /pmc/articles/PMC9679131/ /pubmed/36420237 http://dx.doi.org/10.7759/cureus.30594 Text en Copyright © 2022, K et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Gastroenterology K, Sugumaran Jajal, Vasistha M Nekarakanti, Phani K Choudhary, Devendra Nag, Hirdaya H Gallbladder Cancer With Jaundice: Surgery Versus No Surgery |
title | Gallbladder Cancer With Jaundice: Surgery Versus No Surgery |
title_full | Gallbladder Cancer With Jaundice: Surgery Versus No Surgery |
title_fullStr | Gallbladder Cancer With Jaundice: Surgery Versus No Surgery |
title_full_unstemmed | Gallbladder Cancer With Jaundice: Surgery Versus No Surgery |
title_short | Gallbladder Cancer With Jaundice: Surgery Versus No Surgery |
title_sort | gallbladder cancer with jaundice: surgery versus no surgery |
topic | Gastroenterology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679131/ https://www.ncbi.nlm.nih.gov/pubmed/36420237 http://dx.doi.org/10.7759/cureus.30594 |
work_keys_str_mv | AT ksugumaran gallbladdercancerwithjaundicesurgeryversusnosurgery AT jajalvasistham gallbladdercancerwithjaundicesurgeryversusnosurgery AT nekarakantiphanik gallbladdercancerwithjaundicesurgeryversusnosurgery AT choudharydevendra gallbladdercancerwithjaundicesurgeryversusnosurgery AT naghirdayah gallbladdercancerwithjaundicesurgeryversusnosurgery |